CU23351A3 - PARASITICIDAL COMPOSITION OF DELAYED ACTION CONTAINING A SALICIEANILIDA COMPOUND, A POLYMERIC SPECIES AND AT LEAST ANOTHER ANTI-PARASITARY COMPOUND - Google Patents
PARASITICIDAL COMPOSITION OF DELAYED ACTION CONTAINING A SALICIEANILIDA COMPOUND, A POLYMERIC SPECIES AND AT LEAST ANOTHER ANTI-PARASITARY COMPOUNDInfo
- Publication number
- CU23351A3 CU23351A3 CU20040188A CU20040188A CU23351A3 CU 23351 A3 CU23351 A3 CU 23351A3 CU 20040188 A CU20040188 A CU 20040188A CU 20040188 A CU20040188 A CU 20040188A CU 23351 A3 CU23351 A3 CU 23351A3
- Authority
- CU
- Cuba
- Prior art keywords
- compound
- salicieanilida
- parasitary
- another anti
- delayed action
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000003111 delayed effect Effects 0.000 title 1
- 230000000590 parasiticidal effect Effects 0.000 title 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 3
- 241001465754 Metazoa Species 0.000 abstract 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract 3
- JMPFSEBWVLAJKM-UHFFFAOYSA-N N-{5-chloro-4-[(4-chlorophenyl)(cyano)methyl]-2-methylphenyl}-2-hydroxy-3,5-diiodobenzamide Chemical compound ClC=1C=C(NC(=O)C=2C(=C(I)C=C(I)C=2)O)C(C)=CC=1C(C#N)C1=CC=C(Cl)C=C1 JMPFSEBWVLAJKM-UHFFFAOYSA-N 0.000 abstract 2
- 229950004178 closantel Drugs 0.000 abstract 2
- 244000045947 parasite Species 0.000 abstract 2
- 229920000642 polymer Polymers 0.000 abstract 2
- -1 polyoxypropylene Polymers 0.000 abstract 2
- 241000894007 species Species 0.000 abstract 2
- AZSNMRSAGSSBNP-UHFFFAOYSA-N 22,23-dihydroavermectin B1a Natural products C1CC(C)C(C(C)CC)OC21OC(CC=C(C)C(OC1OC(C)C(OC3OC(C)C(O)C(OC)C3)C(OC)C1)C(C)C=CC=C1C3(C(C(=O)O4)C=C(C)C(O)C3OC1)O)CC4C2 AZSNMRSAGSSBNP-UHFFFAOYSA-N 0.000 abstract 1
- SPBDXSGPUHCETR-JFUDTMANSA-N 8883yp2r6d Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O[C@@H]([C@@H](C)CC4)C(C)C)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 SPBDXSGPUHCETR-JFUDTMANSA-N 0.000 abstract 1
- 239000005660 Abamectin Substances 0.000 abstract 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 abstract 1
- 239000002202 Polyethylene glycol Substances 0.000 abstract 1
- 229920001400 block copolymer Polymers 0.000 abstract 1
- 230000037058 blood plasma level Effects 0.000 abstract 1
- 230000037396 body weight Effects 0.000 abstract 1
- 229960002418 ivermectin Drugs 0.000 abstract 1
- FXWHFKOXMBTCMP-WMEDONTMSA-N milbemycin Natural products COC1C2OCC3=C/C=C/C(C)CC(=CCC4CC(CC5(O4)OC(C)C(C)C(OC(=O)C(C)CC(C)C)C5O)OC(=O)C(C=C1C)C23O)C FXWHFKOXMBTCMP-WMEDONTMSA-N 0.000 abstract 1
- ZLBGSRMUSVULIE-GSMJGMFJSA-N milbemycin A3 Chemical class O1[C@H](C)[C@@H](C)CC[C@@]11O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 ZLBGSRMUSVULIE-GSMJGMFJSA-N 0.000 abstract 1
- 229920001223 polyethylene glycol Polymers 0.000 abstract 1
- 229920001451 polypropylene glycol Polymers 0.000 abstract 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 abstract 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 1
- WKEDVNSFRWHDNR-UHFFFAOYSA-N salicylanilide Chemical compound OC1=CC=CC=C1C(=O)NC1=CC=CC=C1 WKEDVNSFRWHDNR-UHFFFAOYSA-N 0.000 abstract 1
- 229950000975 salicylanilide Drugs 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Una composición preparada para el tratamiento de animales con parásitos, parásitos que se saben susceptibles a al menos una entre avermectinas, milbemicinas o salicilanilidas, c0omprende por ejemplo ivermectina en una cantidad comprendida entre el 0,1 y el 10% (p/v), un solvente seleccionado dentro del grupo consistente en glicerol formal, propilenglicol, polietillenglicol y combinaciones de los mismos, y una salicilanilida tal como closantel en una dosis requerida por el animal a ser tratado, habitualmente de alrededor de 2,5 mg/kg vivo de peso del animal a ser tratado, una especie polimérica seleccionada dentro del grupo consistente en polivinilpirrolidona y copolímeros de bloque de polioxipropileno/polioxietileno, dichas especie poliméricas mejoran la biodisponibilidad del closantel en la medida que pueden lograrse niveles en plasma sanguíneo de dicho compuesto de más de alrededor de 20 ppm a lo largo de un período de tratamiento.A composition prepared for the treatment of animals with parasites, parasites that are known to be susceptible to at least one of avermectins, milbemycins or salicylanilides, comprises, for example, ivermectin in an amount between 0.1 and 10% (w / v), a solvent selected from the group consisting of formal glycerol, propylene glycol, polyethylene glycol and combinations thereof, and a salicylanilide such as closantel in a dose required by the animal to be treated, usually about 2.5 mg / kg body weight of the animal to be treated, a polymer species selected from the group consisting of polyvinylpyrrolidone and polyoxypropylene / polyoxyethylene block copolymers, said polymer species improve the bioavailability of the closantel as blood plasma levels of said compound of more than about can be achieved 20 ppm over a period of treatment.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20040188A CU23351A3 (en) | 2004-09-01 | 2004-09-01 | PARASITICIDAL COMPOSITION OF DELAYED ACTION CONTAINING A SALICIEANILIDA COMPOUND, A POLYMERIC SPECIES AND AT LEAST ANOTHER ANTI-PARASITARY COMPOUND |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20040188A CU23351A3 (en) | 2004-09-01 | 2004-09-01 | PARASITICIDAL COMPOSITION OF DELAYED ACTION CONTAINING A SALICIEANILIDA COMPOUND, A POLYMERIC SPECIES AND AT LEAST ANOTHER ANTI-PARASITARY COMPOUND |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CU23351A3 true CU23351A3 (en) | 2009-03-16 |
Family
ID=40473330
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU20040188A CU23351A3 (en) | 2004-09-01 | 2004-09-01 | PARASITICIDAL COMPOSITION OF DELAYED ACTION CONTAINING A SALICIEANILIDA COMPOUND, A POLYMERIC SPECIES AND AT LEAST ANOTHER ANTI-PARASITARY COMPOUND |
Country Status (1)
| Country | Link |
|---|---|
| CU (1) | CU23351A3 (en) |
-
2004
- 2004-09-01 CU CU20040188A patent/CU23351A3/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR038852A1 (en) | A PARASITICIATED COMPOSITION | |
| ECSP045407A (en) | BENZAZOLES SUBSTITUTED AND THE USE OF THE SAME AS INHIBITORS OF QUINASA RAF | |
| ECSP066959A (en) | MACROCICLICAL COMPOUNDS AS INHIBITORS OF VIRAL REPLICATION | |
| AR055095A1 (en) | NEW MACROCICLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION | |
| AR054064A1 (en) | COMPOSITION WITH ACTIVE PHARMACEUTICAL INGREDIENT BASED ON CANABINOID FOR IMPROVED DOSE FORMS | |
| AR044248A1 (en) | AGENTS TO COMBAT PARASITES IN ANIMALS | |
| ATE548034T1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING DROXIDOPA | |
| AR046510A1 (en) | COMPOSITION OF A VEGF ANTAGONIST AND AN ANTI-PROLIFERATIVE AGENT | |
| CR7140A (en) | ANTRANILAMIDS WITH A SIDE CHAIN OF A HETEROARYLSULFONIL, METHODS FOR THE PRODUCTION OF THE SAME, ITS USE AS A MEDICINAL OR DIAGNOSTIC AGENT AND PHARMACEUTICAL PREPARATIONS CONTAINED IN SUCH COMPOUNDS | |
| CR9195A (en) | FUNGICIDE BLENDS | |
| AR076139A1 (en) | METHOD FOR TREATMENT OF CROPS WITH AN ENCAPSULATED PESTICIDE. | |
| CR20120151A (en) | COMBINATIONS OF ACTIVE COMPOUNDS | |
| CO6280389A2 (en) | COMBINATIONS OF ACTIVE PRINCIPLES CONTAINING ISOTIANILO, A FIPROL COMPOUND AND A NEONICOTINOID COMPOSITE | |
| AR038853A1 (en) | AN INJECTABLE PARASITICIATED COMPOSITION | |
| AR061830A1 (en) | HIGHLY EFFICIENT LIQUID FORMULATION OF PIRETROIDS | |
| CU20070094A7 (en) | SOLID ORAL DOSAGE FORMS CONTAINING A LOW ESTRADIOL DOSE | |
| CR9839A (en) | PHOTOSTABLE PHARMACEUTICAL COMPOSITION CONTAINING BRIVUDINE FOR THE TREATMENT OF HERPETIC CHERATITIS | |
| CL2011001775A1 (en) | Veterinary antiparasitic composition comprising doramectin, cottonseed oil, benzyl benzoate and one or more among preservatives, excipients and fat-soluble vitamin. | |
| AR013067A1 (en) | INSECTICIDE AND ACARICIDE COMPOSITIONS AND PROCESS FOR THEIR PREPARATION. | |
| ECSP066360A (en) | PARASITICIATED COMPOSITION | |
| AR048291A1 (en) | IMPROVED DISTRIBUTION AND PREPARATION OF MANAGED COMPOSITIONS | |
| CU23351A3 (en) | PARASITICIDAL COMPOSITION OF DELAYED ACTION CONTAINING A SALICIEANILIDA COMPOUND, A POLYMERIC SPECIES AND AT LEAST ANOTHER ANTI-PARASITARY COMPOUND | |
| AR056558A1 (en) | METHODS TO STABILIZE OPHTHALM COMPOSITIONS | |
| AR040287A1 (en) | PLATFORM FOR TRANSDERMAL FORMULATIONS (PFT) | |
| AR052178A1 (en) | SYNERGIC COMBINATION OF HERBICIDAL ACTIVE SUBSTANCES |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Lapse (for not paying fees) |